Research Analysts’ downgrades for Thursday, August 10th:
Autohome (NYSE:ATHM) was downgraded by analysts at ValuEngine from a buy rating to a hold rating.
BioCryst Pharmaceuticals (NASDAQ:BCRX) was downgraded by analysts at ValuEngine from a hold rating to a sell rating.
Cheniere Energy Partners LP Holdings (AMEX:CQH) was downgraded by analysts at BidaskClub from a hold rating to a sell rating.
Cheniere Energy Partners (AMEX:CQP) was downgraded by analysts at ValuEngine from a hold rating to a sell rating.
Castlight Health, inc. (NYSE:CSLT) was downgraded by analysts at ValuEngine from a hold rating to a sell rating.
Rocket Fuel (NASDAQ:FUEL) was downgraded by analysts at ValuEngine from a hold rating to a sell rating.
Gold Standard Ventures Corp (NYSEMKT:GSV) was downgraded by analysts at ValuEngine from a hold rating to a sell rating.
Huaneng Power International (NYSE:HNP) was downgraded by analysts at ValuEngine from a strong-buy rating to a buy rating.
Lipocine (NASDAQ:LPCN) was downgraded by analysts at ValuEngine from a hold rating to a sell rating.
Novelion Therapeutics (NASDAQ:NVLN) (TSE:QLT) was downgraded by analysts at ValuEngine from a hold rating to a sell rating.
CPI Card Group (NASDAQ:PMTS) (TSE:PNT) was downgraded by analysts at ValuEngine from a hold rating to a sell rating.
Redwood Trust (NYSE:RWT) was downgraded by analysts at BidaskClub from a buy rating to a hold rating.
Banco Santander, (NYSE:SAN) was downgraded by analysts at Zacks Investment Research from a buy rating to a sell rating. According to Zacks, “Banco Santander SA is the biggest bank in Spain and the biggest international bank in Latin America as well. The Bank concentrates its activities in Andalucia, Castilla-Leon, Catalonia, Madrid, Valencia and Cantabria. The Bank provides banking services for individuals and companies, leasing, factoring, stockbrokerage and mutual fund services. “
Strongbridge Biopharma PLC (NASDAQ:SBBP) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Strongbridge Biopharma PLC is a biopharmaceutical company which develops, acquires and commercializes product candidates that target rare diseases. Its product candidate consists of COR-003, is a cortisol inhibitor, for the treatment of endogenous Cushing’s syndrome, COR-004 and COR-005 to treat acromegaly, BP-2001, the treatment of diabetes which are in different clinical trial. Strongbridge Biopharma PLC is based in Trevose, Pennsylvania. “
Stellus Capital Investment Corporation (NYSE:SCM) was downgraded by analysts at ValuEngine from a strong-buy rating to a buy rating.
Siemens AG (NASDAQ:SIEGY) was downgraded by analysts at ValuEngine from a buy rating to a hold rating.
Southern Company (The) (NYSE:SO) was downgraded by analysts at BidaskClub from a hold rating to a sell rating.
Social Reality (NASDAQ:SRAX) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Social Reality, Inc. is an internet advertising company. It provides automated digital platform technology and social management software for internet advertising. The Company’s business platform consists of Social Reality Ad Exchange, GroupAd, SRAX MD, SRAX DI and Steel Media. It provides a platform which allows website publishers to sell their media inventory to digital adverting buyers. Social Reality, Inc. is headquartered in Los Angeles, California. “
Stemline Therapeutics (NASDAQ:STML) was downgraded by analysts at ValuEngine from a hold rating to a sell rating.
Trustmark Corporation (NASDAQ:TRMK) was downgraded by analysts at ValuEngine from a buy rating to a hold rating.
Unilever plc (LON:ULVR) was downgraded by analysts at Royal Bank Of Canada to an underperform rating. Royal Bank Of Canada currently has GBX 3,800 ($49.49) price target on the stock.
Uqm Technologies (NYSEMKT:UQM) was downgraded by analysts at ValuEngine from a hold rating to a sell rating.
Westport Fuel Systems (NASDAQ:WPRT) (TSE:WPT) was downgraded by analysts at ValuEngine from a hold rating to a sell rating.